• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

MU Stage 3 Proposed Rule: 5 Toughest Measures for Physicians

by Jasmine Pennic 04/03/2015 2 Comments

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

 

MU Sttage 3 Proposed Rule Survey 3

61 percent of physicians feel the federal government has not done a fair job with the MU stage 3 proposed rule, according to a recent survey conducted by QuantiaMD and exclusively designed by Healthcare Informatics editors. For the survey, QuantiaMD, a Waltham, Mass.-based social network for physicians asked physicians in its network about proposed Meaningful Use Stage 3 rules to support the path to nationwide interoperability. 

In response to an open answered question on what they wish would be different about the proposed rule, one respondent wrote: “I do not think that the creators of these rules have any idea how difficult it is to get patients to sign up to access their records. Practices/hospital takes the penalties for patients not signing up. Our population is largely Hispanic, elderly, and uneducated. From our experience, they have no interest in signing up for this.”

Toughest Stage 3 Proposed Rule Measures for Physicians

Stage 3 MU Measures

The survey results revealed the toughest MU stage 3 proposed measures for physicians to meet as: 

– Patient Engagement (53 percent)

– Coordination of Care (43 percent)

– Public Health (35 percent)

– Clinical Decision Support (24 percent)

– CPOE (19 percent)

– Protecting ePHI (18 percent)

– HIE (16 percent)

– eRX (10 percent)

Other key findings of the survey include:

MU Sttage 3 Proposed Rule Survey 2 MU Sttage 3 Proposed Rule Survey 4 MU Sttage 3 Proposed Rule Survey 1

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Clinical Decision Support, CPOE, decision support, HIE, interoperability, Meaningful Use, meaningful use stage 3, patient engagement, physicians, Public Health

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Samsung Acquires Xealth to Accelerate Connected Care Vision

Samsung Acquires Xealth to Accelerate Connected Care Vision

AI Dominates Digital Health Investment in First Half of 2025

Rock Health Report: AI Dominates Digital Health Investment in First Half of 2025

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |